MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Inflammation"

  • MDS Virtual Congress 2021

    Post-Covid-19 Parkinson’s disease: a Brazilian case series.

    J. Tavares, D. Oliveira, S. Gaspar, C. Gomes, M. Neto, P. Neto (Fortaleza, Brazil)

    Objective: To describe two patients with post-COVID-19 Parkinson’s disease (PD) and discuss their possible causes. Background: PD is a neurodegenerative disorder characterized by motor and…
  • MDS Virtual Congress 2021

    Ultrastructural Characterization of Monocytes in Parkinson’s Disease and GBA mutations

    GM. Riboldi, S. Dilipkumar, A. Sowa, A. Allen, K. Astudillo, J. Crary, S. Frucht, T. Raj, W. Janseen (New York, USA)

    Objective: To identify morphological changes in circulating CD14+ monocytes in manifesting and non-manifesting carriers of mutations of the GBA gene and Parkinson’s disease (PD). Background: Mutations of…
  • MDS Virtual Congress 2021

    Mutations in GBA and LRRK2 are not associated with increased inflammatory markers

    A. Thaler, N. Omer, N. Giladi, T. Gurevich, A. Bar Shira, O. Goldstein, M. Gana-Weisz, M. Kestenbaum, J. Shirvan, J. Cedarbaum, A. Orr-Urtreger, S. Shenhar-Tsarfaty, A. Mirelman (Tel-Aviv, Israel)

    Objective: To assess central and peripheral cytokines among Parkinson's disease (PD) patients with mutations in the LRRK2 and GBA genes as well as among non-manifesting…
  • MDS Virtual Congress 2021

    Integrated Multi-omics of the Gut Microbiome Reveal 2-Hydroxypyridine as a Novel Molecule Relevant to Parkinson’s Disease Pathogenesis

    V. Aho, JP. Trezzi, C. Jäger, S. Schade, C. Trenkwalder, A. Janzen, U. Heins-Marroquin, C. Linster, G. Gomez Giro, J. Schwamborn, T. Kitami, M. Thomas, K. Schmit, C. Martin-Gallausiaux, M. Buttini, M. Mittelbronn, W. Oertel, B. Mollenhauer, P. Wilmes (Esch-Sur-Alzette, Luxembourg)

    Objective: To search for molecular links between Parkinson’s disease (PD) pathogenesis and gut microbes based on integrated multi-omic analyses of fecal samples from patients with…
  • MDS Virtual Congress 2021

    Targeted plasmaproteome identifies a distinct biomarker panel in early and prodromal Parkinson’s disease

    M. Bartl, J. Hallqvist, M. Dakna, S. Schade, C. Trenkwalder, F. Sixel-Döring, B. Mollenhauer, K. Mills (Göttingen, Germany)

    Objective: To identify protein biomarkers in plasma of patients with Parkinson’s disease (PD). Background: Inflammation plays a key role in the initiation and progression of…
  • MDS Virtual Congress 2021

    The gut microbiome in Parkinson’s disease: longitudinal insights into disease progression and the use of device-assisted therapies.

    M. Lubomski, X. Xu, A. Holmes, S. Mueller, J. Yang, C. Sue, R. Davis (St Leonards, Australia)

    Objective: We investigated the temporal stability of gut microbiome (GM) profiles from Parkinson’s disease (PD) patients initiating device-assisted therapies (DAT) and in a separate cohort…
  • MDS Virtual Congress 2021

    Gut microbiota and nutritional profiles of Parkinson’s disease patients.

    M. Lubomski, X. Xu, A. Holmes, S. Mueller, J. Yang, C. Sue, R. Davis (St Leonards, Australia)

    Objective: We investigated the gut microbiome (GM) composition in association with various clinical features and nutritional data in a large cross-sectional Australian Parkinson’s disease (PD)…
  • MDS Virtual Congress 2020

    Development and validation of a profile of peripheral immune biomarkers for Parkinson’s disease: A multicenter, retrospective study

    Y. Li, J. Liu (Shanghai, China)

    Objective: This multicenter study was designed to investigate the association between multiple peripheral immune biomarkers and the risk of Parkinson’s disease (PD). Background: Several studies…
  • MDS Virtual Congress 2020

    Predicting the effects of Tumor Necrosis Factor inhibition on the risk and age at onset of Parkinson’s disease: A Mendelian randomization study

    X. Kang, A. Ploner, N. Pedersen, J. Ludvigsson, S. Bandres-Ciga, A. Noyce, K. Wirdefeldt, D. Williams (Stockholm, Sweden)

    Objective: To evaluate whether inhibition of Tumor Necrosis Factor (TNF) signaling may reduce the risk of Parkinson’s disease (PD) and/or delay onset of PD. Background:…
  • MDS Virtual Congress 2020

    Neuroinflammation and Myelin changes in MSA-P evaluated using Advanced Diffusion MRI and Myelin Sensitive Imaging Techniques

    T. Ogawa, T. Hatano, K. Kamagata, C. Andica, H. Takeshige-Amano, W. Uchida, D. Kamiyama, Y. Shimo, G. Oyama, A. Umemura, H. Iwamuro, M. Ito, M. Hori, S. Aoki, N. Hattori (Tokyo, Japan)

    Objective: To determine more specific neuropathologies of the white matter in patients with multiple system atrophy-parkinsonian variant (MSA-P) using multi-shell diffusion magnetic resonance imaging (MRI)…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 25
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley